At the University of Bonn, scientists have done something that quietly reshapes our understanding of biological time: they took blood cells from donors spanning a century of human life and coaxed them into becoming neural stem cells that, at the molecular level, grew young again. The epigenetic clocks within these reprogrammed cells — the chemical records of a life lived — reset to a fraction of their original age, suggesting that cellular identity and cellular age may be more separable than we once believed. This work does not promise immortality, but it does ask a profound question: if the m
Bonn researchers reverse aging in blood cells converted to neural stem cells
Epigenetic age plummeted to roughly five percent of donor age
Mark
So they took old blood cells and made them younger. How exactly does that work?
Mimi
They used a virus to deliver two proteins that act like switches for gene activity. These switches told the blood cells to become neural stem cells instead. The clever part is they did it directly—no intermediate step where the cells go back to being embryo-like first.
Luke
And the epigenetic age dropped to five percent of the donor's age. That's the claim. But how confident are we in that measurement? The authors themselves mention possible mathematical errors in their assessment models.
Mimi
Fair point. They're being honest about the limitations. But the DNA damage and mitochondrial toxicity improvements—those are separate measurements that all pointed the same direction.
Mark
Why does this matter? What's the actual application?
Mimi
If you can reverse aging in cells, you might eventually repair damaged tissue, treat neurodegenerative diseases, or understand aging well enough to slow it down in living people.
Luke
Might. The big unknown is whether this works in an actual organism. Lab cells are one thing. A living body is another.
Mark
Did they test it in animals?
Luke
The source doesn't mention animal studies. Just the lab work with human cells from fifteen donors.
Mimi
Which is why they're careful to call this foundational research. It's the proof of concept. The next steps would be testing in living systems.
Mark
So we're at the beginning of something, not the end.
Mimi
Exactly. This is the door opening, not the destination.
El Pulso
- Blood cells from a 101-year-old donor were reprogrammed into neural stem cells whose molecular age collapsed to roughly five percent of the donor's actual age — a reversal that challenges assumptions about biological time.
- The transformation bypassed the usual embryo-like intermediate state, using just two transcription factors delivered by viral vector to flip the cells' identity within twelve days.
- Rejuvenation wasn't cosmetic: researchers measured real reductions in DNA damage, mitochondrial toxicity, and age-related chemical markers — and the effect persisted even when cell division was suppressed.
- The scientific community is watching carefully but cautiously, as the study lacked a natural comparison group and the authors themselves warn that lab behavior may not survive the complexity of a living organism.
- The findings crack open a door in regenerative medicine and aging research, but the corridor beyond remains largely unmapped.
At the University of Bonn, scientists have done something that quietly reshapes our understanding of biological time: they took blood cells from donors spanning a century of human life and coaxed them into becoming neural stem cells that, at the molecular level, grew young again. The epigenetic clocks within these reprogrammed cells — the chemical records of a life lived — reset to a fraction of their original age, suggesting that cellular identity and cellular age may be more separable than we once believed. This work does not promise immortality, but it does ask a profound question: if the marks of aging can be erased in a dish, what does that mean for the living body that carries them?
A research team at the University of Bonn has achieved something that strains the boundary between science and science fiction: blood cells drawn from donors as old as 101 were converted into neural stem cells — and in the process, those cells grew molecularly younger.
The starting material was erythroid progenitor cells, the precursors to red blood cells. Using a viral vector to deliver two transcription factors — proteins that act as master switches for gene activity — the researchers bypassed the conventional reprogramming route that first pushes cells into an embryo-like state. Within about twelve days, the blood cells began shedding their original identity and taking on the hallmarks of neural tissue.
What followed was the study's most striking finding. Epigenetic age — a molecular clock embedded in the chemical tags that regulate gene expression — normally mirrors a donor's biological history. After reprogramming, it did not. Over fifty to one hundred days, the epigenetic age of the new neural stem cells plummeted, landing at roughly five percent of the donor's chronological age. Alongside this reset came measurable improvements: less DNA damage, reduced mitochondrial toxicity, and altered protein expression. Crucially, the rejuvenation continued even when cell division was suppressed, ruling out rapid proliferation as a simple explanation.
The authors are deliberate in their restraint. They note that the mathematical models underlying epigenetic age calculations could carry errors, that no naturally aged neural stem cells were included for comparison, and — most significantly — that cells in a laboratory dish face none of the immune pressures, nutrient constraints, or tissue-level signaling of a living body. The work illuminates how aging is written into cells and hints that it might be rewritten, but whether that rewriting survives contact with an actual organism remains an open and consequential question.
A team at the University of Bonn has pulled off something that sounds like science fiction: they took blood cells from people ranging in age from newborns to a 101-year-old, converted them into neural stem cells, and watched as those cells grew younger—not just functionally, but at the molecular level.
The researchers worked with erythroid progenitor cells, the precursor cells that normally become red blood cells. Using a virus as a delivery vehicle, they inserted two transcription factors—proteins that act as master switches for gene activity—directly into these cells. The approach was deliberately designed to skip the intermediate step that many cell reprogramming techniques rely on, where cells are first pushed back into an embryo-like state before being nudged toward their new identity. About twelve days after the viral vector arrived, the blood cells began shedding their blood-specific proteins and acquiring the hallmarks of neural cells. The team tracked these changes using DNA methylation analysis and RNA sequencing, techniques that read the chemical tags cells use to control which genes turn on and off.
What happened next is where the work becomes genuinely striking. The researchers measured something called epigenetic age—a molecular clock that tracks how old a cell's gene-regulation system has become, independent of the donor's actual age. Before reprogramming, this epigenetic age matched what you'd expect: older donors had older cells. But after the transformation, something unexpected unfolded. Over the course of fifty to one hundred days, the epigenetic age of these newly minted neural stem cells plummeted. By the end, cells from a 101-year-old donor had an epigenetic age equivalent to roughly five percent of that person's actual age. Most of the age-related chemical markers that accumulate over a lifetime reset within about fifty days.
The rejuvenation came with measurable improvements in cellular health. The researchers observed less DNA damage, lower toxicity in the mitochondria—the cell's power plants—and shifts in how the cells expressed proteins and recycled their own components. Remarkably, this reversal of aging continued even when the team suppressed the cells' ability to divide, suggesting the rejuvenation wasn't simply a side effect of rapid cell growth.
But the authors are careful about what they claim. They flag several limitations that matter. The mathematical models used to calculate epigenetic age could contain errors. The study lacked a comparison group of naturally aged neural stem cells to benchmark against. And perhaps most importantly, they acknowledge that cells behaving in a laboratory dish may not behave the same way inside a living organism, where they'd face immune responses, nutrient constraints, and the complex signaling environment of actual tissue. The work opens a door to understanding how cells age and potentially how to reverse that process, but it also leaves many questions unanswered about whether this rejuvenation would survive contact with the body.
Citas Notables
Rejuvenation continued even under conditions that suppressed cell division— Study authors, as reported by ScienceAlert
Quieres la nota completa?
Lee el original en UA.NEWS ↗
Health & Medicine